Pretreatment insights into primary sarcoma tissues using a novel approach of ex-vivo functional profiling to quantify cytotoxic and anti-proliferative effects of chemo and targeted therapies. This is ...
PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ ...
Growth is being fueled by the rising demand for personalized, patient-derived treatments that minimize immune rejection and ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...
A multi-institutional clinical trial conducted at the UNC Lineberger Comprehensive Cancer Center and 21 other U.S. sites found that a single administration of autologous tumor-infiltrating lymphocyte ...
The newly developed platform bridges this gap by combining induced pluripotent stem cell (iPSC)-derived liver organoids with each donor's autologous CD8⁺ T cells—the immune cells responsible for ...
Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programsVispa-cel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results